Literature DB >> 17516495

Defined protein and animal component-free NS0 fed-batch culture.

Erika Spens1, Lena Häggström.   

Abstract

A chemically defined protein and animal component-free fed-batch process for an NS0 cell line producing a human IgG(1) antibody has been developed. The fed-batch feed profile was optimised in a step-wise manner. Depletion of measurable compounds was determined by direct analysis. The cellular need for non-measurable compounds was tested by continued culturing of cell suspension, removed from the bioreactor, in shake-flasks supplemented with critical substances. In the final fed-batch culture, 8.4 x 10(6) viable cells mL(-1) and 625 mg antibody L(-1) was obtained as compared to 2.3 x 10(6) cells mL(-1) and 70 mg antibody L(-1) in batch. The increase in cell density, in combination with a prolonged declining phase where antibody formation continued, resulted in a 6.2-fold increase in total cell yield, a 10.5-fold increase in viable cell hours and an 11.4-fold increase in product yield. These improvements were obtained by using a feed with glucose, glutamine, amino acids, lipids, sodium selenite, ethanolamine and vitamins. Specifically, supplementation with lipids (cholesterol) had a drastic effect on the maximum viable cell density. Calcium, magnesium and potassium were not depleted and a feed also containing iron, lithium, manganese, phosphorous and zinc did not significantly enhance the cell yield. The growth and death profiles in the final fed-batch indicated that nutrient deprivation was not the main cause of cell death. The ammonium concentration and the osmolality increased to potentially inhibitory levels, but an imbalance in the supply of growth/survival factors may also contribute to termination of the culture. Copyright 2007 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17516495     DOI: 10.1002/bit.21509

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  7 in total

Review 1.  Cell culture processes for monoclonal antibody production.

Authors:  Feng Li; Natarajan Vijayasankaran; Amy Yijuan Shen; Robert Kiss; Ashraf Amanullah
Journal:  MAbs       Date:  2010-09-01       Impact factor: 5.857

2.  Rational development of a serum-free medium and fed-batch process for a GS-CHO cell line expressing recombinant antibody.

Authors:  Huifeng Zhang; Haibin Wang; Mei Liu; Tao Zhang; Ji Zhang; Xiangjing Wang; Wensheng Xiang
Journal:  Cytotechnology       Date:  2012-08-21       Impact factor: 2.058

3.  Expression of recombinant antibodies.

Authors:  André Frenzel; Michael Hust; Thomas Schirrmann
Journal:  Front Immunol       Date:  2013-07-29       Impact factor: 7.561

4.  Very high density of Chinese hamster ovary cells in perfusion by alternating tangential flow or tangential flow filtration in WAVE Bioreactor™-part II: Applications for antibody production and cryopreservation.

Authors:  Marie-Françoise Clincke; Carin Mölleryd; Puneeth K Samani; Eva Lindskog; Eric Fäldt; Kieron Walsh; Véronique Chotteau
Journal:  Biotechnol Prog       Date:  2013-05-21

Review 5.  Innovations in the Insect Cell Expression System for Industrial Recombinant Vaccine Antigen Production.

Authors:  Manon M J Cox
Journal:  Vaccines (Basel)       Date:  2021-12-20

Review 6.  Advances in recombinant antibody manufacturing.

Authors:  Renate Kunert; David Reinhart
Journal:  Appl Microbiol Biotechnol       Date:  2016-03-03       Impact factor: 4.813

7.  Population balance modelling captures host cell protein dynamics in CHO cell cultures.

Authors:  Sakhr Alhuthali; Cleo Kontoravdi
Journal:  PLoS One       Date:  2022-03-23       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.